menu
    • menu

    Company profile for Abionyx Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ABIONYX Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment The biotech assets inherited from CERENIS Therapeutics constitute a rich portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as a HDL targeted drug delivery platform in ...
    ABIONYX Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment The biotech assets inherited from CERENIS Therapeutics constitute a rich portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as a HDL targeted drug delivery platform in oncology , more specifically in immuno oncology and chemotherapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abionyx PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    33 43 av. Georges Pompidou Bât. D2 31130 Balma
    Telephone
    Telephone
    +33 5 62 24 97 06
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abionyx.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ABIONYX Pharma, SEBIA Partner To Revolutionize Global Sepsis
    ABIONYX Pharma, SEBIA Partner To Revolutionize Global Sepsis

    20 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251120289715/en/ABIONYX-Pharma-and-SEBIA-Announce-an-Exclusive-Global-Strategic-Partnership-to-Transform-Sepsis-Diagnosis

    BUSINESSWIRE
    20 Nov 2025
    Share Share
    Abionyx Pharma in Advanced Talks With IHU on Sepsis
    Abionyx Pharma in Advanced Talks With IHU on Sepsis

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251111036210/en/ABIONYX-Pharma-Enters-Advanced-Strategic-Discussions-with-IHU-SEPSIS-the-Worlds-First-Center-Dedicated-to-Sepsis

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    ABIONYX Pharma Validates Apoa-I Genetic Role In Sepsis: NATURE
    ABIONYX Pharma Validates Apoa-I Genetic Role In Sepsis: NATURE

    21 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251021992375/en/ABIONYX-Pharma-Announces-Landmark-Validation-A-Study-Published-in-NATURE-Confirms-Genetic-Causality-of-Apolipoprotein-A-I-ApoA-I-in-Sepsis

    BUSINESSWIRE
    21 Oct 2025
    Share Share
    ABIONYX Advances LCAT Deficiency Treatment On World Rare Disease Day
    ABIONYX Advances LCAT Deficiency Treatment On World Rare Disease Day

    28 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250227229247/en

    BUSINESSWIRE
    28 Feb 2025
    Share Share
    ABIONYX Wins €8.7M France 2030 Grant To Fight Sepsis
    ABIONYX Wins €8.7M France 2030 Grant To Fight Sepsis

    20 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250219591056/en

    BUSINESSWIRE
    20 Feb 2025
    Share Share
    Abionyx Pharma Approves Resolutions at Combined General Meeting
    Abionyx Pharma Approves Resolutions at Combined General Meeting

    29 Nov 2024

    // INVESTING

    https://www.investing.com/news/press-releases/abionyx-pharma-announces-the-approval-of-all-resolutions-put-to-the-vote-at-its-combined-general-meeting-on-november-28-2024-3747172

    INVESTING
    29 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search